Mangone Flavia Rotea, Miracca Elisabete C, Feilotter Harriet E, Mulligan Lois M, Nagai Maria Aparecida
Laboratory of Molecular Genetics, Center for Translational Research in Oncology, Av Dr Arnaldo, 251, 8th Floor, CEP 01246-000 São Paulo, Brazil.
Department of Pathology and Molecular Medicine, Richardson Laboratory, Queen's University, 88 Stuart Street, Kingston, Ontario K7L 3N6 Canada.
Springerplus. 2015 Jan 15;4:23. doi: 10.1186/s40064-015-0787-z. eCollection 2015.
The Ataxia-telangiectasia mutated (ATM) gene encodes a multifunctional kinase, which is linked to important cellular functions. Women heterozygous for ATM mutations have an estimated relative risk of developing breast cancer of 3.8. However, the pattern of ATM mutations and their role in breast cancer etiology has been controversial and remains unclear. In the present study, we investigated the frequency and spectrum of ATM mutations in a series of sporadic breast cancers and controls from the Brazilian population.
Using PCR-Single Strand Conformation Polymorphism (SSCP) analysis and direct DNA sequencing, we screened a panel of 100 consecutive, unselected sporadic breast tumors and 100 matched controls for all 62 coding exons and flanking introns of the ATM gene.
Several polymorphisms were detected in 12 of the 62 coding exons of the ATM gene. These polymorphisms were observed in both breast cancer patients and the control population. In addition, evidence of potential ATM mutations was observed in 7 of the 100 breast cancer cases analyzed. These potential mutations included six missense variants found in exon 13 (p.L546V), exon 14 (p.P604S), exon 20 (p.T935R), exon 42 (p.G2023R), exon 49 (p.L2307F), and exon 50 (p.L2332P) and one nonsense mutation in exon 39 (p.R1882X), which was predicted to generate a truncated protein.
Our results corroborate the hypothesis that sporadic breast tumors may occur in carriers of low penetrance ATM mutant alleles and these mutations confer different levels of breast cancer risk.
共济失调毛细血管扩张症突变(ATM)基因编码一种多功能激酶,其与重要的细胞功能相关。ATM突变的杂合女性患乳腺癌的估计相对风险为3.8。然而,ATM突变模式及其在乳腺癌病因学中的作用一直存在争议且仍不清楚。在本研究中,我们调查了巴西人群中一系列散发性乳腺癌及对照中ATM突变的频率和谱。
使用聚合酶链反应-单链构象多态性(PCR-SSCP)分析和直接DNA测序,我们对100例连续、未经选择的散发性乳腺肿瘤及100例匹配对照进行了ATM基因所有62个编码外显子及其侧翼内含子的筛查。
在ATM基因的62个编码外显子中的12个中检测到了几种多态性。这些多态性在乳腺癌患者和对照人群中均有观察到。此外,在分析的100例乳腺癌病例中的7例中观察到了潜在的ATM突变证据。这些潜在突变包括在外显子13(p.L546V)、外显子14(p.P604S)、外显子20(p.T935R)、外显子42(p.G2023R)、外显子49(p.L2307F)和外显子50(p.L2332P)中发现的6个错义变体以及在外显子39(p.R1882X)中的1个无义突变,该突变预计会产生截短蛋白。
我们的结果证实了以下假设,即散发性乳腺肿瘤可能发生在低外显率ATM突变等位基因携带者中,并且这些突变赋予不同水平的乳腺癌风险。